407 related articles for article (PubMed ID: 7585040)
21. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.
Scherer HU; van der Woude D; Ioan-Facsinay A; el Bannoudi H; Trouw LA; Wang J; Häupl T; Burmester GR; Deelder AM; Huizinga TW; Wuhrer M; Toes RE
Arthritis Rheum; 2010 Jun; 62(6):1620-9. PubMed ID: 20178128
[TBL] [Abstract][Full Text] [Related]
22. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
[TBL] [Abstract][Full Text] [Related]
23. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.
Rombouts Y; Willemze A; van Beers JJ; Shi J; Kerkman PF; van Toorn L; Janssen GM; Zaldumbide A; Hoeben RC; Pruijn GJ; Deelder AM; Wolbink G; Rispens T; van Veelen PA; Huizinga TW; Wuhrer M; Trouw LA; Scherer HU; Toes RE
Ann Rheum Dis; 2016 Mar; 75(3):578-85. PubMed ID: 25587188
[TBL] [Abstract][Full Text] [Related]
24. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy.
Yamaguchi Y; Nishimura M; Nagano M; Yagi H; Sasakawa H; Uchida K; Shitara K; Kato K
Biochim Biophys Acta; 2006 Apr; 1760(4):693-700. PubMed ID: 16343775
[TBL] [Abstract][Full Text] [Related]
25. Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans.
Hafkenscheid L; Bondt A; Scherer HU; Huizinga TW; Wuhrer M; Toes RE; Rombouts Y
Mol Cell Proteomics; 2017 Feb; 16(2):278-287. PubMed ID: 27956708
[TBL] [Abstract][Full Text] [Related]
26. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content.
Soltys AJ; Hay FC; Bond A; Axford JS; Jones MG; Randen I; Thompson KM; Natvig JB
Scand J Immunol; 1994 Aug; 40(2):135-43. PubMed ID: 8047835
[TBL] [Abstract][Full Text] [Related]
27. Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor.
Zou G; Ochiai H; Huang W; Yang Q; Li C; Wang LX
J Am Chem Soc; 2011 Nov; 133(46):18975-91. PubMed ID: 22004528
[TBL] [Abstract][Full Text] [Related]
28. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis.
Rademacher TW; Parekh RB; Dwek RA; Isenberg D; Rook G; Axford JS; Roitt I
Springer Semin Immunopathol; 1988; 10(2-3):231-49. PubMed ID: 3055379
[No Abstract] [Full Text] [Related]
29. IgG and rheumatoid factor at a glance.
Roitt IM; Sumar N
Clin Exp Rheumatol; 1990; 8 Suppl 5():89-91. PubMed ID: 2245533
[TBL] [Abstract][Full Text] [Related]
30. Rheumatoid factors and complex formation. The role of light-chain framework sequences and glycosylation.
Hay FC; Jones MG; Bond A; Soltys AJ
Clin Orthop Relat Res; 1991 Apr; (265):54-62. PubMed ID: 1901258
[TBL] [Abstract][Full Text] [Related]
31. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.
Wright A; Morrison SL
J Exp Med; 1994 Sep; 180(3):1087-96. PubMed ID: 8064227
[TBL] [Abstract][Full Text] [Related]
32. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.
Mimura Y; Church S; Ghirlando R; Ashton PR; Dong S; Goodall M; Lund J; Jefferis R
Mol Immunol; 2000; 37(12-13):697-706. PubMed ID: 11275255
[TBL] [Abstract][Full Text] [Related]
33. IgG rheumatoid factors and self-association of these antibodies.
Mannik M; Nardella FA
Clin Rheum Dis; 1985 Dec; 11(3):551-72. PubMed ID: 2416505
[TBL] [Abstract][Full Text] [Related]
34. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
35. Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG.
Tsuchiya N; Endo T; Matsuta K; Yoshinoya S; Aikawa T; Kosuge E; Takeuchi F; Miyamoto T; Kobata A
J Rheumatol; 1989 Mar; 16(3):285-90. PubMed ID: 2498512
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis.
Magorivska I; Döncző B; Dumych T; Karmash A; Boichuk M; Hychka K; Mihalj M; Szabó M; Csánky E; Rech J; Guttman A; Vari SG; Bilyy R
Autoimmunity; 2018 May; 51(3):111-117. PubMed ID: 29733234
[TBL] [Abstract][Full Text] [Related]
37. The structure of a human rheumatoid factor bound to IgG Fc.
Sutton BJ; Corper AL; Sohi MK; Jefferis R; Beale D; Taussig MJ
Adv Exp Med Biol; 1998; 435():41-50. PubMed ID: 9498063
[TBL] [Abstract][Full Text] [Related]
38. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
39. Agalactosyl IgG in aggregates from the rheumatoid joint.
Leader KA; Lastra GC; Kirwan JR; Elson CJ
Br J Rheumatol; 1996 Apr; 35(4):335-41. PubMed ID: 8624636
[TBL] [Abstract][Full Text] [Related]
40. The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies.
Collin M; Ehlers M
Exp Dermatol; 2013 Aug; 22(8):511-4. PubMed ID: 23808883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
